Compound Capital is a thesis-driven, research-centric venture capital firm based in New York. The firm invests across deep technology sectors including AI/ML, robotics, biotechnology, blockchain/crypto, and biosecurity, publishing extensive research and theses to guide its investment strategy. Compound works hands-on with technical founders to solve complex scientific and engineering challenges, communicate breakthrough innovations, and scale commercialization. The firm maintains a research-heavy approach with dedicated venture partners across specialized domains including computational biology, data science, decentralized science, and autonomous systems. Compound also operates a grants program and publishes regularly on emerging technology narratives, ranging from biomanufacturing and autonomous science to decentralized infrastructure and AI scaling laws.

Profile auto-generated from public sources — details unverified.